173 related articles for article (PubMed ID: 22266247)
1. Methotrexate is an effective and safe adjuvant therapy for pemphigus vulgaris.
Baum S; Greenberger S; Samuelov L; Solomon M; Lyakhovitsky A; Trau H; Barzilai A
Eur J Dermatol; 2012; 22(1):83-7. PubMed ID: 22266247
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and safety of methotrexate in recalcitrant cutaneous lupus erythematosus: results of a retrospective study in 43 patients.
Wenzel J; Brähler S; Bauer R; Bieber T; Tüting T
Br J Dermatol; 2005 Jul; 153(1):157-62. PubMed ID: 16029342
[TBL] [Abstract][Full Text] [Related]
3. Methotrexate in the treatment of pemphigus vulgaris: experience in 23 patients.
Tran KD; Wolverton JE; Soter NA
Br J Dermatol; 2013 Oct; 169(4):916-21. PubMed ID: 23772610
[TBL] [Abstract][Full Text] [Related]
4. The impact of stratifying initial dose of corticosteroids by severity of pemphigus vulgaris on long-term disease severity.
Lyakhovitsky A; Baum S; Scope A; Amichai B; Barzilai A; Rimer J; Trau H
Int J Dermatol; 2011 Aug; 50(8):1014-9. PubMed ID: 21781080
[TBL] [Abstract][Full Text] [Related]
5. Corticosteroid sparing effect of low dose methotrexate treatment in adult Still's disease.
Fautrel B; Borget C; Rozenberg S; Meyer O; Le Loët X; Masson C; Koeger AC; Kahn MF; Bourgeois P
J Rheumatol; 1999 Feb; 26(2):373-8. PubMed ID: 9972972
[TBL] [Abstract][Full Text] [Related]
6. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
Werth VP
Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
[TBL] [Abstract][Full Text] [Related]
7. Analysis of current data on the use of methotrexate in the treatment of pemphigus and pemphigoid.
Gürcan HM; Ahmed AR
Br J Dermatol; 2009 Oct; 161(4):723-31. PubMed ID: 19548961
[TBL] [Abstract][Full Text] [Related]
8. Immunosuppressants and prednisone in pemphigus vulgaris: therapeutic results obtained in 63 patients between 1961 and 1975.
Lever WF; Schaumburg-Lever G
Arch Dermatol; 1977 Sep; 113(9):1236-41. PubMed ID: 900969
[TBL] [Abstract][Full Text] [Related]
9. Oropharyngeal pemphigus vulgaris and clinical remission: a long-term, longitudinal study.
Mignogna MD; Fortuna G; Leuci S; Ruoppo E
Am J Clin Dermatol; 2010; 11(2):137-45. PubMed ID: 20141235
[TBL] [Abstract][Full Text] [Related]
10. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris.
Engineer L; Bhol KC; Ahmed AR
J Am Acad Dermatol; 2000 Dec; 43(6):1049-57. PubMed ID: 11100022
[TBL] [Abstract][Full Text] [Related]
11. Dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris.
Heaphy MR; Albrecht J; Werth VP
Arch Dermatol; 2005 Jun; 141(6):699-702. PubMed ID: 15967915
[TBL] [Abstract][Full Text] [Related]
12. Double blind, randomized, placebo controlled clinical trial of methotrexate in systemic lupus erythematosus.
Carneiro JR; Sato EI
J Rheumatol; 1999 Jun; 26(6):1275-9. PubMed ID: 10381042
[TBL] [Abstract][Full Text] [Related]
13. Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults.
Lyakhovitsky A; Barzilai A; Heyman R; Baum S; Amichai B; Solomon M; Shpiro D; Trau H
J Eur Acad Dermatol Venereol; 2010 Jan; 24(1):43-9. PubMed ID: 19552716
[TBL] [Abstract][Full Text] [Related]
14. High dose oral prednisone vs. prednisone plus azathioprine for the treatment of oral pemphigus: a retrospective, bi-centre, comparative study.
Chaidemenos G; Apalla Z; Koussidou T; Papagarifallou I; Ioannides D
J Eur Acad Dermatol Venereol; 2011 Feb; 25(2):206-10. PubMed ID: 20569289
[TBL] [Abstract][Full Text] [Related]
15. Kaposi's sarcoma resolves after sirolimus therapy in a patient with pemphigus vulgaris.
Saggar S; Zeichner JA; Brown TT; Phelps RG; Cohen SR
Arch Dermatol; 2008 May; 144(5):654-7. PubMed ID: 18490593
[TBL] [Abstract][Full Text] [Related]
16. Pulsed intravenous cyclophosphamide and methylprednisolone therapy in refractory pemphigus.
Saha M; Powell AM; Bhogal B; Black MM; Groves RW
Br J Dermatol; 2010 Apr; 162(4):790-7. PubMed ID: 19922532
[TBL] [Abstract][Full Text] [Related]
17. Pemphigus vulgaris: a case-based update.
Ben Lagha N; Poulesquen V; Roujeau JC; Alantar A; Maman L
J Can Dent Assoc; 2005 Oct; 71(9):667-72. PubMed ID: 16271165
[TBL] [Abstract][Full Text] [Related]
18. The role of IVIg treatment in severe pemphigus vulgaris.
Baum S; Scope A; Barzilai A; Azizi E; Trau H
J Eur Acad Dermatol Venereol; 2006 May; 20(5):548-52. PubMed ID: 16684282
[TBL] [Abstract][Full Text] [Related]
19. Improved protocol for treatment of pemphigus vulgaris with protein A immunoadsorption.
Shimanovich I; Herzog S; Schmidt E; Opitz A; Klinker E; Bröcker EB; Goebeler M; Zillikens D
Clin Exp Dermatol; 2006 Nov; 31(6):768-74. PubMed ID: 16824051
[TBL] [Abstract][Full Text] [Related]
20. Gold: an old drug still working in refractory pemphigus.
Iranzo P; Alsina MM; Martínez-De Pablo I; Segura S; Mascaró JM; Herrero C
J Eur Acad Dermatol Venereol; 2007 Aug; 21(7):902-7. PubMed ID: 17658998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
